| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |